Related Experiment Video
Updated: May 29, 2026

Curcuminoid-Mediated Antimicrobial Photodynamic Therapy on a Murine Model of Oral Candidiasis
Published on: October 27, 2023
Ochroconis gallopava: a dematiaceous mold causing infections in transplant recipients
Zubair A Qureshi1, Eun J Kwak, M Hong Nguyen
1Department of Medicine, University of Pittsburgh Medical Center, University of Pittsburgh, Pittsburgh, PA 15213, USA.
Abstract:
The dematiaceous mold Ochroconis gallopava is increasingly recognized as a human pathogen. Infection is almost always associated with immunosuppression. We describe a case with a unique presentation in a kidney transplant recipient and retrospectively review all 10 cases of O. gallopava at our institution over 18 yr, all in organ transplant recipients. Sixty percent of infections at our institution occurred in the last five yr studied. Infection generally occurred late after transplantation, and pulmonary infection was the most common manifestation. Use of almetuzumab for induction was associated with infection in the first six months post-transplant (p = 0.03). Attributable mortality at six months was 20%. Ochroconis gallopava is a rare but important pathogen in immunosuppressed individuals and organ transplantation is the most common underlying condition. Pulmonary involvement is the most common manifestation among patients with organ transplant. Optimal therapy remains undefined. Prognosis in organ transplant recipients is good if infection is diagnosed prior to dissemination.
Insights
Ochroconis gallopava is an emerging fungal pathogen in transplant recipients, often causing lung infections. Early diagnosis in organ transplant patients improves prognosis, though optimal treatment is still unknown.
Area of Science:
- Medical Mycology
- Infectious Diseases
- Transplantation Immunology
Background:
- Ochroconis gallopava, a dematiaceous mold, is increasingly identified as a human pathogen.
- Infections typically occur in immunosuppressed individuals, particularly organ transplant recipients.
- Organ transplantation is the most common underlying condition associated with O. gallopava infections.
Observation:
- A retrospective review of 10 O. gallopava cases in organ transplant recipients over 18 years was conducted.
- A significant increase in infections (60%) was observed in the last five years of the study period.
- Pulmonary infection was the most common clinical manifestation, often occurring late after transplantation.
Findings:
- Use of alemtuzumab for induction therapy was associated with infection within six months post-transplant (p = 0.03).
- The attributable mortality rate at six months post-infection was 20%.
- O. gallopava is a rare but significant pathogen in immunocompromised populations.
Implications:
- Pulmonary involvement is the predominant manifestation in organ transplant recipients.
- Early diagnosis of O. gallopava infection in transplant recipients is crucial for a favorable prognosis.
- Optimal therapeutic strategies for O. gallopava infections remain to be defined.
Related Concept Videos
Cryptococcal Meningitis
Skin Diseases and Disorders
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Candidiasis
Fungal Group Zygomycota
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
Antifungal Agents